| EAU guidelines on renal cell carcinoma: 2014 update B Ljungberg, K Bensalah, S Canfield, S Dabestani, F Hofmann, M Hora, ... European urology 67 (5), 913-924, 2015 | 4865* | 2015 |
| Apalutamide for metastatic, castration-sensitive prostate cancer KN Chi, N Agarwal, A Bjartell, BH Chung, AJ Pereira de Santana Gomes, ... New England Journal of Medicine 381 (1), 13-24, 2019 | 1482 | 2019 |
| European association of urology guidelines on renal cell carcinoma: the 2019 update B Ljungberg, L Albiges, Y Abu-Ghanem, K Bensalah, S Dabestani, ... European urology 75 (5), 799-810, 2019 | 1426 | 2019 |
| Renal cell carcinoma guideline B Ljungberg, DC Hanbury, MA Kuczyk, AS Merseburger, PFA Mulders, ... European urology 51 (6), 1502-1510, 2007 | 1185* | 2007 |
| Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines A Stenzl, NC Cowan, M De Santis, MA Kuczyk, AS Merseburger, MJ Ribal, ... European urology 59 (6), 1009-1018, 2011 | 766 | 2011 |
| Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration W Abida, A Patnaik, D Campbell, J Shapiro, AH Bryce, R McDermott, ... Journal of Clinical Oncology 38 (32), 3763-3772, 2020 | 683 | 2020 |
| Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy L Marconi, S Dabestani, TB Lam, F Hofmann, F Stewart, J Norrie, A Bex, ... European urology 69 (4), 660-673, 2016 | 634 | 2016 |
| The updated EAU guidelines on muscle-invasive and metastatic bladder cancer A Stenzl, NC Cowan, M De Santis, G Jakse, MA Kuczyk, AS Merseburger, ... European urology 55 (4), 815-825, 2009 | 607* | 2009 |
| Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial T Powles, T Csőszi, M Özgüroğlu, N Matsubara, L Géczi, SYS Cheng, ... The Lancet Oncology 22 (7), 931-945, 2021 | 558 | 2021 |
| Apalutamide in patients with metastatic castration-sensitive prostate cancer: final survival analysis of the randomized, double-blind, phase III TITAN study KN Chi, S Chowdhury, A Bjartell, BH Chung, ... Journal of Clinical Oncology 39 (20), 2294-2303, 2021 | 454 | 2021 |
| Non-BRCA DNA damage repair gene alterations and response to the PARP inhibitor rucaparib in metastatic castration-resistant prostate cancer: analysis from the phase II TRITON2 … W Abida, D Campbell, A Patnaik, JD Shapiro, B Sautois, NJ Vogelzang, ... Clinical Cancer Research 26 (11), 2487-2496, 2020 | 382 | 2020 |
| EAU guidelines on laser technologies TRW Herrmann, EN Liatsikos, U Nagele, O Traxer, AS Merseburger, ... European urology 61 (4), 783-795, 2012 | 318 | 2012 |
| Impact of gender on bladder cancer incidence, staging, and prognosis H Fajkovic, JA Halpern, EK Cha, A Bahadori, TF Chromecki, ... World journal of urology 29, 457-463, 2011 | 279 | 2011 |
| MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies AG Anastasiadis, MP Lichy, U Nagele, MA Kuczyk, AS Merseburger, ... European urology 50 (4), 738-749, 2006 | 247 | 2006 |
| Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised … T Powles, P Tomczak, SH Park, B Venugopal, T Ferguson, ... The lancet oncology 23 (9), 1133-1144, 2022 | 239 | 2022 |
| Current evidence of transurethral en-bloc resection of nonmuscle invasive bladder cancer MW Kramer, V Altieri, R Hurle, L Lusuardi, AS Merseburger, J Rassweiler, ... European urology focus 3 (6), 567-576, 2017 | 237 | 2017 |
| Updated European Association of Urology guidelines on renal cell carcinoma: immune checkpoint inhibition is the new backbone in first-line treatment of metastatic clear-cell … L Albiges, T Powles, M Staehler, K Bensalah, RH Giles, M Hora, ... European urology 76 (2), 151-156, 2019 | 223 | 2019 |
| En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc … MW Kramer, JJ Rassweiler, J Klein, A Martov, N Baykov, L Lusuardi, ... World journal of urology 33, 1937-1943, 2015 | 220 | 2015 |
| Updated European Association of Urology Guidelines: recommendations for the treatment of first-line metastatic clear cell renal cancer T Powles, L Albiges, M Staehler, K Bensalah, S Dabestani, RH Giles, ... European urology 73 (3), 311-315, 2018 | 219 | 2018 |
| Expression of prostate-specific membrane antigen (PSMA) on biopsies is an independent risk stratifier of prostate cancer patients at time of initial diagnosis MC Hupe, C Philippi, D Roth, C Kümpers, J Ribbat-Idel, F Becker, V Joerg, ... Frontiers in oncology 8, 623, 2018 | 188 | 2018 |
Milan HoraDept. of Urology, University Hospital Plzeň, CZVerified email at fnplzen.cz
